相关实验视频

Updated: Sep 17, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

在治疗帕金森病的ProSavin®基因疗法后,深度大脑刺激是耐受良好且有效的

S Senova¹, K Edakawa¹, G Gouello¹

¹Department of Neurosurgery, Henri Mondor Academic Hospital, Université Paris Est Créteil, INSERM Laboratory U955 of Translational NeuroPsychiatry, Institut Mondor de Recherche Biomédicale, France.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

|July 2, 2025

概括

深度大脑刺激 (DBS) 是安全有效的帕金森病 (PD) 患者先前接受过基因治疗 (GT). 这种方法,即使在疾病过程中晚些时候启动,也显示出与标准DBS治疗相似的结果.

科学领域:

神经学神经学
神经外科神经外科
基因治疗基因治疗

背景情况:

帕金森病 (PD) 是通过多巴胺作用药物来管理的,但运动波动需要先进的治疗.
脑下核深度大脑刺激 (DBS) 是高级PD的标准治疗方法.
针对条状多巴胺替代的基因疗法 (GT) 在PD患者中显示出初步的希望.

研究的目的:

评估DBS在帕金森病患者的安全性和运动疗效,这些患者之前接受过基因疗法.
为了比较基因疗法治疗队列 (GT/DBS) 与标准DBS队列中的DBS结果.

主要方法:

对八名接受GT,随后接受DBS的PD患者的回顾性分析 (GT/DBS组).
与仅接受DBS治疗的84名PD患者 (DBS组) 的比较.
运动功能的评估 (UPDRS III分数) 和药物使用 (LEDD) 在DBS前和12个月后.

主要成果:

GT/DBS组在疾病进展的显著晚期接受了DBS.
这两组的严重不良事件和整体运动改善率相似 (UPDRS III MEDSOFF评分).
GT/DBS组在DBS后的轴运动症状显著减少.

结论:

亚thalamic核DBS是一种耐受性良好的,有效的治疗PD患者之前的基因治疗.
DBS提供与标准 DBS相比的安全性和有效性,即使在GT治疗患者的疾病过程中晚些时候给予DBS.

关键词:

深度大脑刺激是什么?基因治疗是一种基因疗法.帕金森病的疾病.

更多相关视频

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...